Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates

Fortress Biotech (FBIO) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of$ 0.79. This compares to loss of $0.53 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of 67.09%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.27 per share when it actually produced a loss of $0.76, delivering a surprise of -181.48%. Over the last four quarters, ...